| NEWRON PHARMACEUT. EO-,20 |
| Italien |
| Gesundheit |
| IT0004147952 / A0LF18 |
| NP5 (Frankfurt) |
| FRA:NP5, ETR:NP5, NP5:GR |
| - |
| https://www.newron.com/ |
|
Newron Pharmaceuticals SpA is a biopharmaceutical company headquartered in Bresso near Milan, Italy, specializing in the development of neuroscience-based treatments. Founded in 1999, the company focu..
>Volltext.. |
| 426.85 Mio. EUR |
| 436.22 Mio. EUR |
| 59.99 Mio. EUR |
| 35.46 Mio. EUR |
| 25.39 Mio. EUR |
| 1.27 EUR |
| 52.16 Mio. EUR |
| 26.43 Mio. EUR |
| 24.71 Mio. EUR |
| 1.08 |
| 770.27% |
| - |
| - |
| - |
| - |
| - |
| NEWRON |
| 16.02.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|